stoxline Quote Chart Rank Option Currency Glossary
  
(TTI)
  0 (0%)    11-30 07:31
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-11-28 2:22:42 PM
Short term     
Mid term     
Targets 6-month :  9.75 1-year :  11.39
Resists First :  8.35 Second :  9.75
Pivot price 7.64
Supports First :  7.33 Second :  6.69
MAs MA(5) :  7.63 MA(20) :  7.52
MA(100) :  5.51 MA(250) :  4.29
MACD MACD :  0.2 Signal :  0.2
%K %D K(14,3) :  51.8 D(3) :  50.3
RSI RSI(14): 56.9
52-week High :  8.35 Low :  2.02
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TTI ] has closed below upper band by 37.0%. Bollinger Bands are 15.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 7.88 - 7.91 7.91 - 7.95
Low: 7.37 - 7.41 7.41 - 7.45
Close: 7.75 - 7.82 7.82 - 7.88
Company Description

Headline News

Sun, 30 Nov 2025
NEW ISSUE: Read the November/December 2025 edition of TTi magazine online now! - Traffic Technology Today

Sun, 30 Nov 2025
Shammarran waggaa 28'tti maaliif miidhaginaaf yaala baqaqsanii hodhuu 'plastic surgery' filachaa jiru? - BBC

Sat, 29 Nov 2025
Is There Hidden Value in TTI Enterprise Limiteds Business Model - Market Sentiment Indicators & Chat With Other Investors on Daily Signals - earlytimes.in

Fri, 28 Nov 2025
TETRA Technologies (NYSE:TTI) shareholder returns have been fantastic, earning 803% in 5 years - simplywall.st

Wed, 26 Nov 2025
Tetra Technologies (NYSE:TTI) Shares Down 5.5% - What's Next? - MarketBeat

Mon, 24 Nov 2025
Thiogenesis Therapeutics Expands on Plans for Phase 3 Pivotal Trial of TTI-0102 in Nephropathic Cystinosis - Newsfile

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 134 (M)
Shares Float 126 (M)
Held by Insiders 6.1 (%)
Held by Institutions 82.2 (%)
Shares Short 5,340 (K)
Shares Short P.Month 4,670 (K)
Stock Financials
EPS 0.92
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.22
Profit Margin 19.7 %
Operating Margin 7.2 %
Return on Assets (ttm) 6.6 %
Return on Equity (ttm) 54 %
Qtrly Rev. Growth 8.1 %
Gross Profit (p.s.) 1.46
Sales Per Share 4.62
EBITDA (p.s.) 0.73
Qtrly Earnings Growth 0 %
Operating Cash Flow 74 (M)
Levered Free Cash Flow -1 (M)
Stock Valuations
PE Ratio 8.45
PEG Ratio 0
Price to Book value 3.5
Price to Sales 1.68
Price to Cash Flow 14
Stock Dividends
Dividend 0.1
Forward Dividend 0
Dividend Yield 1.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android